Want to track 4974 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Takara Bio Inc. (4974) Statistics
Valuation metrics
Market Cap 104.88B
Enterprise value 128.29B
Trailing P/E (ttm) -14.35
Forward P/E 32.24
PEG ratio 0.03
Price/Sales (ttm) 3.42
Price/Book (mrq) 1.33
Enterprise Value/Revenue 3.18
Enterprise Value/EBITDA -41.34
Overview
Shares outstanding 120.42M
Float 14.3M
Shares short -
% Held by insiders 0.87%
% Held by institutions 0.05%
Average volume (10 days) 219.84K
Average volume (90 days) 444.79K
Price summary
52-Week low 759
52-Week high 1,150
Beta 0.44
50-Day moving average 1,142.69
200-Day moving average 1,005.08
Dividends and splits
Forward annual dividend rate 68
Forward annual dividend yield 0.0595%
Trailing annual dividend rate 17
Trailing annual dividend yield 0.0149%
5-Year annual dividend yield 1.98%
Payout ratio -0.21
Dividend Date -
Ex-Dividend Date -
Last split factor 400:1
Last split Date 29 Mar 2011
Financials
Fiscal year
Fiscal year ends 31 Mar 2026
Most recent quarter (mrq) 30 Jun 2025
Profitability
Profit margin -0.24%
Operating margin -0.12%
Operational effectiveness
Return on assets -0.07%
Return on equity -0.09%
Income Statement
Revenue (ttm) 40.32B
Revenue per share (ttm) 334.84
Quarterly revenue growth (yoy) -0.24%
Gross profit (ttm) 20.26B
EBITDA 633M
Net income to common (ttm) -9.6B
Diluted EPS (ttm) -79.71
Quarterly earnings growth (yoy) -0.99%
Balance Sheet
Total cash (mrq) 20.45B
Total cash per share (mrq) 169.85
Total debt (mrq) 10.98B
Total Debt/Equity (mrq) 0.11
Current ratio (mrq) 5.76%
Book value per share (mrq) 863.47
Cash Flow
Cash flow statement 3.58B
Levered free cash flow (LFCF) -6.2B
